Cargando…

An In-Silico Evaluation of Anthraquinones as Potential Inhibitors of DNA Gyrase B of Mycobacterium tuberculosis

The World Health Organization reported that tuberculosis remains on the list of the top ten threats to public health worldwide. Among the main causes is the limited effectiveness of treatments due to the emergence of resistant strains of Mycobacterium tuberculosis. One of the main drug targets studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amorim, Juliana Carolina, Cabrera Bermeo, Andrea E., Vásquez Urgilés, Viviana E., Martínez León, Maritza R., Carpio Arévalo, Juan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783175/ https://www.ncbi.nlm.nih.gov/pubmed/36557686 http://dx.doi.org/10.3390/microorganisms10122434

Ejemplares similares

Virtual screening, optimization and molecular dynamics analyses highlighting a pyrrolo[1,2-a]quinazoline derivative as a potential inhibitor of DNA gyrase B of Mycobacterium tuberculosis
por: Arévalo, Juan Marcelo Carpio, et al.
Publicado: (2022)

A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus
por: Ganapathy, Uday S., et al.
Publicado: (2021)

Recognition of DNA Supercoil Geometry by Mycobacterium tuberculosis Gyrase
por: Ashley, Rachel E., et al.
Publicado: (2017)

The role of Ca(2+) in the activity of Mycobacterium tuberculosis DNA gyrase
por: Karkare, Shantanu, et al.
Publicado: (2012)

Identification of novel bacterial DNA gyrase inhibitors: An in silico study
por: Rahimi, Hamzeh, et al.
Publicado: (2016)

Structural Insights into the Quinolone Resistance Mechanism of Mycobacterium tuberculosis DNA Gyrase
por: Piton, Jérémie, et al.
Publicado: (2010)

Mycobacterium tuberculosis Inhibitors Based on Arylated Quinoline Carboxylic Acid Backbones with Anti-Mtb Gyrase Activity
por: Quimque, Mark Tristan J., et al.
Publicado: (2023)

Activity of Tricyclic Pyrrolopyrimidine Gyrase B Inhibitor against Mycobacterium abscessus
por: Madani, Abdeldjalil, et al.
Publicado: (2022)

A Series of Spiropyrimidinetriones that Enhances DNA Cleavage Mediated by Mycobacterium tuberculosis Gyrase
por: Byl, Jo Ann W., et al.
Publicado: (2023)

Schiff Bases of Indoline-2,3-dione: Potential Novel Inhibitors of Mycobacterium Tuberculosis (Mtb) DNA Gyrase (†)
por: Aboul-Fadl, Tarek, et al.
Publicado: (2011)

Spiropyrimidinetriones: a Class of DNA Gyrase Inhibitors with Activity against Mycobacterium tuberculosis and without Cross-Resistance to Fluoroquinolones
por: Basarab, Gregory S., et al.
Publicado: (2022)

In Vitro Resistance against DNA Gyrase Inhibitor SPR719 in Mycobacterium avium and Mycobacterium abscessus
por: Aragaw, Wassihun Wedajo, et al.
Publicado: (2022)

Single-molecule dynamics of DNA gyrase in evolutionarily distant bacteria Mycobacterium tuberculosis and Escherichia coli
por: Galvin, Cooper J., et al.
Publicado: (2023)

Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores
por: Tomašič, Tihomir, et al.
Publicado: (2021)

Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding
por: Sengupta, Sugopa, et al.
Publicado: (2006)

Insights into Pyrazinamidase and DNA Gyrase Protein Structures in Resistant and Susceptible Clinical Isolates of Mycobacterium tuberculosis
por: Ahmadi, Azam, et al.
Publicado: (2016)

Structure-Based Virtual Screening of Benzaldehyde Thiosemicarbazone Derivatives against DNA Gyrase B of Mycobacterium tuberculosis
por: Kistan, Andiyappan, et al.
Publicado: (2021)

Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessus
por: Negatu, Dereje Abate, et al.
Publicado: (2021)

Conditional Silencing by CRISPRi Reveals the Role of DNA Gyrase in Formation of Drug-Tolerant Persister Population in Mycobacterium tuberculosis
por: Choudhary, Eira, et al.
Publicado: (2019)

The Structural Modeling of the Interaction between Levofloxacin and the Mycobacterium tuberculosis Gyrase Catalytic Site Sheds Light on the Mechanisms of Fluoroquinolones Resistant Tuberculosis in Colombian Clinical Isolates
por: Alvarez, N., et al.
Publicado: (2014)

Exploring the Antimicrobial and Pharmacological Potential of NF22 as a Potent Inhibitor of E. coli DNA Gyrase: An In Vitro and In Silico Study
por: Munir, Samman, et al.
Publicado: (2022)

The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA)
por: Huang, You-Yi, et al.
Publicado: (2006)

Vibrio cholerae ParE2 Poisons DNA Gyrase via a Mechanism Distinct from Other Gyrase Inhibitors
por: Yuan, Jie, et al.
Publicado: (2010)

Exploring the Chemical Space of Benzothiazole-Based DNA Gyrase B Inhibitors
por: Skok, Žiga, et al.
Publicado: (2020)

Search for Antimicrobial Activity Among Fifty-Two Natural and Synthetic Compounds Identifies Anthraquinone and Polyacetylene Classes That Inhibit Mycobacterium tuberculosis
por: Pollo, Luiz A. E., et al.
Publicado: (2021)

Alpha-Naphthoflavone as a Novel Scaffold for the Design of Potential Inhibitors of the APH(3’)-IIIa Nucleotide-Binding Site of Enterococcus faecalis
por: Amorim, Juliana Carolina, et al.
Publicado: (2023)

DC-159a Shows Inhibitory Activity against DNA Gyrases of Mycobacterium leprae
por: Yamaguchi, Tomoyuki, et al.
Publicado: (2016)

DNA gyrase could be a crucial regulatory factor for growth and survival of Mycobacterium leprae
por: Kim, Hyun, et al.
Publicado: (2019)

Anthraquinones as Inhibitors of SOS RAS-GEF Activity
por: Fernández-Medarde, Alberto, et al.
Publicado: (2021)

Structural and mechanistic analysis of ATPase inhibitors targeting mycobacterial DNA gyrase
por: Henderson, Sara R, et al.
Publicado: (2020)

In Silico Identification of Possible Inhibitors for Protein Kinase B (PknB) of Mycobacterium tuberculosis
por: Vieira, Tatiana F., et al.
Publicado: (2021)

Impact of Amino Acid Substitutions in B Subunit of DNA Gyrase in Mycobacterium leprae on Fluoroquinolone Resistance
por: Yokoyama, Kazumasa, et al.
Publicado: (2012)

Molecular Characterization of Mycobacterium ulcerans DNA Gyrase and Identification of Mutations Reducing Susceptibility to Quinolones In Vitro
por: Kim, Hyun, et al.
Publicado: (2022)

The Naphthoquinone Diospyrin Is an Inhibitor of DNA Gyrase with a Novel Mechanism of Action
por: Karkare, Shantanu, et al.
Publicado: (2013)

Hybrid Inhibitors of DNA Gyrase A and B: Design, Synthesis and Evaluation
por: Durcik, Martina, et al.
Publicado: (2020)

Development of Anthraquinone Analogues as Phosphoglycerate Mutase 1 Inhibitors
por: Huang, Ke, et al.
Publicado: (2019)

In Silico-Based Discovery of Natural Anthraquinones with Potential against Multidrug-Resistant E. coli
por: Alhadrami, Hani A., et al.
Publicado: (2022)

Designing novel possible kinase inhibitor derivatives as therapeutics against Mycobacterium tuberculosis: An in silico study
por: Shahbaaz, Mohd, et al.
Publicado: (2019)

Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli
por: Dwyer, Daniel J, et al.
Publicado: (2007)

Solution structures of DNA-bound gyrase
por: Baker, Nicole M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3abig906navg3ohtnktr6lg51i